DSM B.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
20 feb 2013 - 06:43
Statutaire naam
DSM B.V.
Titel
DSM is positioned for strong EBITDA growth and increases dividend
Bericht
• DSM reports a solid Q4 with EBITDA of €243 million
• EBITDA full year 2012 of €1,109 million with growth in all clusters, except for caprolactam
• Robust performance of Life Sciences driven by Nutrition
• Materials Sciences performed well, except for caprolactam
• Strong cash generation from operating activities of €730 million in 2012
• Dividend increase proposed to €1.50 per ordinary share
• Outlook 2013: moving towards EBITDA of €1.4 billion
Datum laatste update: 28 juli 2024